Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Epidemiology, Etiology, Diagnosis and Treatment of Prostate Cancer

  • Daniyal, Muhammad (Faculty of Eastern Medicine and Surgery, Hamdard University Karachi Pakistan) ;
  • Siddiqui, Zamir Ali (Department of Pharmacology, Poonch Medical College Rawalakot) ;
  • Akram, Muhammad (Department of Eastern Medicine and Surgery, Faculty of Medical and Health Sciences, The University of Poonch) ;
  • Asif, H.M. (Department of Eastern Medicine and Surgery, Faculty of Medical and Health Sciences, The University of Poonch) ;
  • Sultana, Sabira (University College of Conventional Medicine, Faculty of Pharmacy and Alternative Medicine, The Islamia University of Bahawalpur) ;
  • Khan, Asmatullah (Department of Eastern Medicine and Surgery, Faculty of Medical and Health Sciences, The University of Poonch)
  • Published : 2014.12.18
Download PDF
⟨ Previous Next ⟩

Abstract

Prostate cancer is more common in men over the age of 65 years. There are 15% cases with positive family history of prostate cancer Worldwide. Prostate cancer is the second leading cause of death among the U.S. men. Prostate cancer incidence is strongly related to age with the highest rates in older man. Globally millions of people are suffering from this disease. This study aims to provide awareness about prostate cancer as well as an updated knowledge about the epidemiology, etiology, diagnosis and treatment of prostate cancer.

Keywords

References

  1. Akbari ME, Hosseini SJ, Rezaee A, et al (2008). Incidence of genitourinary cancers in the Islamic Republic of Iran: a survey in 2005. Asian Pac J Cancer Prev, 9, 549-52.
  2. Anderson-Jackson L, McGrowder DA, Alexander-Lindo R (2012). Prostate specific antigen and gleason score in men with prostate cancer at a private diagnostic radiology centre in Western Jamaica. Asian Pac J Cancer Prev, 13, 1453-6. https://doi.org/10.7314/APJCP.2012.13.4.1453
  3. Belbase NP, Agrawal CS, Pokharel PK, et al (2013). Prostate cancer screening in a healthy population cohort in eastern Nepal: an explanatory trial study. Asian Pac J Cancer Prev, 14, 2835-8. https://doi.org/10.7314/APJCP.2013.14.5.2835
  4. Bhurgri Y, Kayani N, Pervez S, et al (2009). Incidence and trends of prostate cancer in Karachi South, 1995-2002. Asian Pac J Cancer Prev, 10, 45-8.
  5. Chan J, Stampfer M, Ma J, et al (2001). Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr, 74, 549-54.
  6. Chen T, Holick M (2003). Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab, 14, 423-30. https://doi.org/10.1016/j.tem.2003.09.004
  7. Garg M, Dalela D, Goel A, et al (2014). Prevention of prostate cancer with vitamins-current perspectives. Asian Pac J Cancer Prev, 15, 1897-904. https://doi.org/10.7314/APJCP.2014.15.5.1897
  8. Harutake S, Atsushi S, Masaaki I, et al (2014). Feedback on baseline use of staging images is important to improve image overuse with newly diagnosed prostate cancer patients. Asian Pac J Cancer Prev, 15, 1707-10. https://doi.org/10.7314/APJCP.2014.15.4.1707
  9. Hayes J, Barry M (2014). Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence, PSA) is elevated in serum, as is prostatic acid phosphatase. JAMA, 311, 1143-49. https://doi.org/10.1001/jama.2014.2085
  10. Hsing A, Chokkalingam A, Gao Y, et al (2002). Allium vegetables and risk of prostate cancer: a population-based study. J Natl Cancer Inst, 94, 1648-51. https://doi.org/10.1093/jnci/94.21.1648
  11. Julie A, Joseph G, Sara A, et al (2009). Men's Knowledge and beliefs about prostate cancer: education, race, and screening status. Ethn Dis, 19, 199-03.
  12. Kang DI, Chung JI, Ha HK, et al (2013). Korean prostate cancer patients have worse disease characteristics than their American counterparts. Asian Pac J Cancer Prev, 14, 6913-7. https://doi.org/10.7314/APJCP.2013.14.11.6913
  13. Klein E, Thompson I, Tangen C, et al (2011). Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 306, 1549-56. https://doi.org/10.1001/jama.2011.1437
  14. Matthew L, Christopher A, Haimanc D, et al (2006). Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA, 103, 14068-73. https://doi.org/10.1073/pnas.0605832103
  15. Meng H, Hu W, Chen Z, et al (2013). Fruit and vegetable intake and prostate cancer risk: a meta-analysis. Asian Pac J Clin Oncol, 10, 133-40. https://doi.org/10.7314/APJCP.2014.15.13.5223
  16. Moore MA, Ariyaratne Y, Badar F, et al (2010). Cancer epidemiology in South Asia - past, present and future. Asian Pac J Cancer Prev, 11, 49-6.
  17. Nath A, Singh JK, Vendan SE, et al (2012). Elevated level of prostate specific antigen among prostate cancer patients and high prevalence in the Gangetic zone of Bihar, India. Asian Pac J Cancer Prev, 13, 221-3. https://doi.org/10.7314/APJCP.2012.13.1.221
  18. Nath A, Singh J, Vendan S, et al (2012). Elevated level of prostate specific antigen among prostate cancer patients and high prevalence in the Gangetic Zone of Bihar, India. Asian Pac J Cancer Prev, 14, 63-8.
  19. Quan H, Fong A, Coster C, (2006). Variation in health services utilization among ethnic populations. CMAJ, 174, 787-91. https://doi.org/10.1503/cmaj.050674
  20. Seisen T, Roupret M, Faix A, et al (2012). The prostate gland: a crossroad between the urinary and the seminal tracts. Prog Urol, 22, 66-80.
  21. Raymundo E, Rice KR, Chen Y, (2010). Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system. BJU Int, 107, 1216-22.
  22. Talaiezadeh A, Tabesh H, Sattari A, et al (2013). Cancer incidence in southwest of Iran: first report from Khuzestan population-based cancer registry, 2002-2009. Asian Pac J Cancer Prev, 14, 7517-22. https://doi.org/10.7314/APJCP.2013.14.12.7517
  23. Titus M, Schell M, Lih F, et al (2005). Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res, 11, 4653-57. https://doi.org/10.1158/1078-0432.CCR-05-0525
  24. Verim L, Yildirim A, Basok EK, et al (2013). Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish men over 75 years of age. Asian Pac J Cancer Prev, 14, 6085-8. https://doi.org/10.7314/APJCP.2013.14.10.6085
  25. Vinjamoori A, Jagannathan J, Shinagare A, et al (2012). Atypical metastases from prostate cancer: 10-year experience at a single institution. AJR. Am J Roentgenol, 199, 367-72. https://doi.org/10.2214/AJR.11.7533
  26. Visser O, Leeuwen F (2004). Cancer risk in first generation migrants in North-Holland/Flevoland, The Netherlands, 1995-2004. Eur J Cancer. 2, 278-80.
  27. Wolk A (2005). Diet, lifestyle and risk of prostate cancer. Acta Oncol, 44, 277-81. https://doi.org/10.1080/02841860510029572
  28. Zheng X-Y, Zhang P, Xie P, et al (2012). Prostate specific antigen velocity (PSAV) and PSAV per initial volume (PSAVD) for early detection of prostate cancer in Chinese men. Asian Pac J Cancer Prev, 13, 5529-33. https://doi.org/10.7314/APJCP.2012.13.11.5529
  29. Zhi Z, Shi-Xin L, Tian Z, (2014). Abiraterone for treatment of metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 15, 1313-20. https://doi.org/10.7314/APJCP.2014.15.3.1313

Cited by

  1. Preventive Effects of Aspirin on Cardiovascular Complications in Prostate Cancer Cases after Endocrinotherapy vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4909
  2. Human Kallikrein-2, Prostate Specific Antigen and Free-Prostate Specific Antigen in Combination to Discriminate Prostate Cancer from Benign Diseases in Syrian Patients vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7085
  3. Conditional PTEN-deficient Mice as a Prostate Cancer Chemoprevention Model vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1827
  4. Detection, quantification, and profiling of PSA: current microarray technologies and future directions vol.6, pp.9, 2016, https://doi.org/10.1039/C5RA20313A
  5. Expression of fatty acid synthase and E-cadherin markers in cancer of the prostate vol.37, pp.1, 2017, https://doi.org/10.1097/01.XEJ.0000520911.05599.41
  6. Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis vol.17, pp.12, 2016, https://doi.org/10.3390/ijms17122071
  7. GIMDA: Graphlet interaction-based MiRNA-disease association prediction vol.22, pp.3, 2017, https://doi.org/10.1111/jcmm.13429
  8. Nontoxic Glucomoringin-Isothiocyanate (GMG-ITC) Rich Soluble Extract Induces Apoptosis and Inhibits Proliferation of Human Prostate Adenocarcinoma Cells (PC-3) vol.10, pp.9, 2018, https://doi.org/10.3390/nu10091174
  9. Bicalutamide enhances fodrin-mediated apoptosis through calpain in LNCaP vol.243, pp.10, 2018, https://doi.org/10.1177/1535370218779780
  10. Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients pp.1573-9546, 2019, https://doi.org/10.1007/s11302-018-9642-3
  11. Trends in Prostate Cancer Prevalence and Radical Prostatectomy Rate according to Age Structural Changes in South Korea between 2005 and 2015 vol.60, pp.3, 2019, https://doi.org/10.3349/ymj.2019.60.3.257
  12. The Quality of Life among Men Receiving Active Surveillance for Prostate Cancer: An Integrative Review vol.7, pp.1, 2019, https://doi.org/10.3390/healthcare7010014